Institute of Biotechnology, University of Helsinki, 00100 Helsinki, Finland
Finnish Institute of Occupational Health, Helsinki, Finland
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00100 Helsinki, Finland
Institute of Mathematics and Computer Science, Ural Federal University, Yekaterinburg, Sverdlovsk Oblast, Russia
Q-Mol L.L.C., San Diego, CA, USA
Department of Mathematics and Statistics, University of Turku, Turku, Finland
Institute of Clinical Medicine, Sognsvannsveien 20, Rikshospitalet, 0372 Oslo, Norway
Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
: Received: 5 August 2016 / Approved: 5 August 2016 / Online: 5 August 2016 (12:41:07 CEST)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to cite:
Söderholm, S.; Fu, Y.; Gaelings, L.; Belanov, S.; Yetukuri, L.; Berlinkov, M.; Cheltov, A.; Anders, S.; Aittokallio, T.; Nyman, T.; Matikainen, S.; Kainov, D. Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction. Preprints2016, 2016080054 (doi: 10.20944/preprints201608.0054.v1).
Söderholm, S.; Fu, Y.; Gaelings, L.; Belanov, S.; Yetukuri, L.; Berlinkov, M.; Cheltov, A.; Anders, S.; Aittokallio, T.; Nyman, T.; Matikainen, S.; Kainov, D. Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction. Preprints 2016, 2016080054 (doi: 10.20944/preprints201608.0054.v1).
Human influenza A viruses (IAVs) cause global pandemics and epidemics. These viruses evolve rapidly, making current treatment options ineffective. To identify novel modulators of IAV-host interactions, we re-analyzed our recent transcriptomics, metabolomics, proteomics, phosphoproteomics, and genomics/virtual ligand screening data. We identified 713 potential modulators targeting 200 cellular and two viral proteins. Anti-influenza activity for 48 of them has been reported previously, whereas the antiviral efficacy of the remaining 665 is unknown. Studying anti-influenza efficacy, immuno-modulating properties and potential resistance of these compounds or their combinations may lead to the discovery of novel modulators of IAV-host interactions, which might be more effective than the currently available anti-influenza therapeutics.